Assessment of outcomes

Haemophilia

Volumn 20, Issue S4, 2014, Pages 114-120

  Blanchette, V S ^a   O'Mahony, B ^b   Mcjames, L ^c   Mahlangu, J N ^d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b IRISH HAEMOPHILIA SOCIETY   (Ireland)

^c National Blood Authority   (Australia)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Assessment; Hemophilia; Outcome; Review

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9 CONCENTRATE;

BLEEDING DISORDER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; ENVIRONMENTAL FACTOR; FINANCIAL MANAGEMENT; FUNCTIONAL INDEPENDENCE SCORE IN HAEMOPHILIA; HAEMOPHILIA ACTIVITIES LIST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEMOPHILIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; AUSTRALIA; HEMOPHILIA A; HEMOPHILIA B; PATIENT SATISFACTION; PHYSICIAN ATTITUDE;

AUSTRALIA; CAPITAL FINANCING; HEMOPHILIA A; HEMOPHILIA B; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PHYSICIAN'S ROLE;

EID: 84899544428     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12426     Document Type: Review

References (46)

1. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHO QOL Group. Psychol Med 1998; 28: 551-8.
2. Gilbert MS. Prophylaxis: musculoskeletal evaluation. Semin Hematol 1993; 30(Suppl. 2): 3-6.
3. Manco-Johnson MJ, Nuss R, Funk S, Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000; 6: 649-57.
4. Hill FGH, Ljung R. Third and fourth Workshops of the European Paediatric Network for haemophilia management. Haemophilia 2003; 9: 223-8.
5. Hilliard P, Funk S, Zourikian N et al. Hemophilia joint health score reliability study. Haemophilia 2006; 12: 518-25.
6. Feldman BM, Funk SM, Bergstrom B-M et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score. Arthritis Care Res (Hoboken) 2011; 63: 223-30.
7. Saulyte Trakymiene S, Ingerslev J, Rageliene L. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania. Haemophilia 2010; 16: 479-86.
8. Bladen M, Main E, Hubert N, Koutoumanou E, Liesner R, Khair K. Factors affecting the Haemophilia Joint Health Score in children with severe haemophilia. Haemophilia 2013; 19: 626-31.
9. Sluiter D, Foppen W, de Kleijn P, Fischer K. Haemophilia Joint Health Score in healthy adults playing sports. Haemophilia 2013; 20: 282-6.
10. Fischer K, de Kleijn P. Using the Haemophilia Joint Health Score for assessment of teenagers and young adults: exploring reliability and validity. Haemophilia 2013; 19: 944-50.
11. Khanum F, Bowen DJ, Kerr BC, Collins PW. Joint health scores in a haemophilia A cohort from Pakistan with minimal or no access to factor VIII concentrate: correlation with thrombin generation and underlying mutation. Haemophilia 2013; doi: 10.1111/hae.12326 [Epub ahead of print].
12. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153-9.
13. Nuss R, Kilcoyne RF, Geraghty S et al. MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage. Haemophilia 2000; 6: 162-9.
14. Lundin B, Pettersson H, Ljung R. A new magnetic resonance imaging scoring method for assessment of haemophilic arthropathy. Haemophilia 2004; 10: 383-9.
15. Arnold WD, Hilgartner MW. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59-A: 287-305.
16. Doria AS, Lundin B, Kilcoyne RF et al. Reliability of progressive and additive MRI scoring systems for evaluation of haemophilic arthropathy in children: expert MRI Working Group of the International Prophylaxis Study Group. Haemophilia 2005; 11: 245-53.
17. Doria AS, Lundin B, Miller S et al. Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children. Haemophilia 2008; 14: 303-14.
18. Lundin B, Manco-Johnson ML, Ignas DM et al. An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group. Haemophilia 2012; 18: 962-70.
19. Zukotynski K, Jarrin J, Babyn PS et al. Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia 2007; 13: 293-304.
20. Keshava S, Gibikote S, Mohanta A, Doria AS. Refinement of a sonographic protocol for assessment of haemophilic arthropathy. Haemophilia 2009; 15: 1168-71.
21. Melchiorre D, Linari S, Innocenti M et al. Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score. Haemophilia 2011; 17: 112-7.
22. Martinoli C, Della Casa Alberighi O, Di Minno G et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost 2013; 109: 1170-9.
23. van Genderen FR, Westers P, Heijnen L et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006; 12: 36-46.
24. van Genderen FR, van Meeteren NL, van der Bom JG et al. Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List. Haemophilia 2004; 10: 565-71.
25. Poonnoose PM, Manigandan C, Thomas R et al. Functional Independence Score in Haemophilia: a new performance-based instrument to measure disability. Haemophilia 2005; 11: 598-602.
26. Poonnoose PM, Thomas R, Keshava SN et al. Psychometric analysis of the Functional Independence Score in Haemophilia (FISH). Haemophilia 2007; 13: 620-6.
27. Young NL, Bradley CS, Blanchette V et al. Development of a health-related quality of life measure for boys with haemophilia: the Canadian Haemophilia Outcomes-Kids Life Assessment Tool (CHO-KLAT). Haemophilia 2004; 10(Suppl. 1): 34-43.
28. Young NL, Bradley CS, Wakefield CD, Barnard D, Blanchette VS, McCusker PJ. How well does the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) measure the quality of life of boys with haemophilia? Pediatr Blood Cancer 2006; 47: 305-11.
29. Bradley CS, Bullinger M, McCusker PJ, Wakefield CD, Blanchette VS, Young NL. Comparing two measures of quality of life for children with haemophilia: the CHO-KLAT and the Haemo-QoL. Haemophilia 2006; 12: 643-53.
30. von Mackensen S, Bullinger M; HAEMO-QOL Group. Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL). Haemophilia 2004; 10(Suppl. 1): 17-25.
31. Arranz P, Remor E, Quintana M et al. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia. Haemophilia 2004; 10: 376-82.
32. Remor E, Arranz P, Quintana M et al. Psychometric field study of the new haemophilia quality of life questionnaire for adults: the 'Hemofilia-QoL'. Haemophilia 2005; 11: 603-10.
33. Rentz A, Flood E, Altisent C et al. Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia. Haemophilia 2008; 14: 1023-34.
34. Szende A, Schramm W, Flood E et al. Health-related quality of life assessment in adult haemophilia patients: a systematic review and evaluation of instruments. Haemophilia 2003; 9: 678-87.
35. de Kleijn P, van Genderen FR, van Meeteren NL. Assessing functional health status in adults with haemophilia: towards a preliminary core set of clinimetric instruments based on a literature search in Rheumatoid Arthritis and Osteoarthritis. Haemophilia 2005; 11: 308-18.
36. O'Mahony B, Noone D, Giangrande PLF, Prihodova L. Haemophilia care in Europe - a survey of 35 countries. Haemophilia 2013; 19: 660-7.
37. Schlenkrich S, Schubert C. Secondary prophylaxis in an adult patient with severe haemophilia A. Factor VIII consumption and effectiveness. Hamostaseologie 2013; 33: 241-4.
38. National Hepatitis C Database for infection acquired through blood and blood products. 2012 Report. Ireland: Health Protection Surveillance Centre. Available at http://www.hpsc.ie/hpsc/A-Z/Hepatitis/HepatitisC/HepatitisCDatabase/. Accessed February 28, 2014.
39. Noone D, Duffy A, O'Mahony B. Retrospective identification of factors which contribute to Hepatitis C treatment decisions in a population of people with haemophilia in Ireland. In press.
40. Giangrande P et al. Kreuth III: European Consensus proposals for treatment of haemophilia with coagulation factor concentrates. In press.
41. Haemophilia: a priority to public health in Romania. Partnership between Ministry of Health, European Haemophilia Consortium and Romanian Haemophilia Association. Memorandum of Understanding, signed, 4th October, 2013. Brussels, Belgium: EHC.
42. Treatment of Haemophilia A and B and von Willebrand Disease. A Systematic Review. Stockholm, Sweden: Swedish Council on Health Technology Assessment.
43. Noone D, O'Mahony B, Pridohova L. A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 20-35 year old men with severe Haemophilia in four European countries. Haemophilia 2011; 17: e831-48.
44. O'Mahony B, Noone D, Tolley K. An introduction to key concepts in health economics for haemophilia organisations. WFH HOD Monograph, 2010; Number 11. Available at http://www.wfh.org. Accessed February 28, 2014.
45. Colvin BT, Astermark J, Fischer K et al.; Inter Disciplinary Working Group. European principles of haemophilia care. Haemophilia 2008; 14:361-74.
46. Hay CRM. Purchasing factor concentrates in the 21st century through competitive tendering. Haemophilia 2013; 19: 660-7.